Elective semaglutide prescription enabled waitlisting and transplantation of otherwise ineligible obese renal transplant candidates
Although transplantation remains the treatment of choice for end-stage renal disease, patients suffering from severe obesity are too often unlisted for this reason. Pre-transplant bariatric surgery is not free of risk and the use of ‘Glucagon Like Peptide-1’analogues in these patients is limited. Ou...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2025-10-01
|
| Serie: | Frontiers in Transplantation |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/frtra.2025.1623096/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|